Recursion Pharmaceuticals, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1282117,
    "name": "Recursion Pharmaceuticals, Inc.",
    "stock_name": "Recursion Pharmaceuticals, Inc.",
    "full_name": "Recursion Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/recursion-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.73",
    "chg": -0.23,
    "chgp": "-4.64%",
    "dir": -1,
    "prev_price": "4.96",
    "mcapval": "2,370.42",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US75629V1044",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "6.67 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/recursion-pharmaceuticals-inc-1282117-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Recursion Pharmaceuticals Hits Day Low at $4.60 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-low-at-460-amid-price-pressure-3680240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RecursionPharma_priceRelatedfactors_3680240.png",
        "date": "2025-11-07 16:36:09",
        "description": "Recursion Pharmaceuticals, Inc. has faced notable stock declines, with a year-to-date drop of 31.66% and a one-year decrease of 32.26%. The company reported negative financial results for two consecutive quarters, including a substantial net loss and low operating cash flow, indicating ongoing challenges in the pharmaceuticals sector."
      },
      {
        "title": "Recursion Pharmaceuticals Hits Day Low at $4.86 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-low-at-486-amid-price-pressure-3676133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RecursionPharma_priceRelatedfactors_3676133.png",
        "date": "2025-11-06 16:13:32",
        "description": "Recursion Pharmaceuticals, Inc. has faced a notable decline in its stock performance, with significant losses over various timeframes. The company reports a challenging financial situation, including a substantial net loss and negative return on equity, raising concerns about its market position within the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-3652147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RecursionPharma_technicaldot_3652147.png",
        "date": "2025-10-28 16:01:32",
        "description": "Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock has experienced fluctuations in price, with notable performance against the S&P 500 over the past week and month, although longer-term returns have faced challenges. Technical indicators present mixed signals regarding market sentiment."
      },
      {
        "title": "Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-recursion-pharmaceuticals-inc-technically-bullish-or-bearish-3651376",
        "imagepath": "",
        "date": "2025-10-28 11:41:47",
        "description": "As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD is mildly bullish, while the monthly MACD also indicates a mildly bullish trend. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly time frames. The Dow Theory supports a mildly bullish stance on both weekly and monthly periods, and the OBV is bullish in both time frames. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%. Overall, the mixed signals suggest a cautious approach...."
      }
    ],
    "total": 19,
    "sid": "1282117",
    "stock_news_url": "https://www.marketsmojo.com/news/recursion-pharmaceuticals-inc-1282117"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Recursion Pharmaceuticals Hits Day Low at $4.60 Amid Price Pressure

2025-11-07 16:36:09

Recursion Pharmaceuticals, Inc. has faced notable stock declines, with a year-to-date drop of 31.66% and a one-year decrease of 32.26%. The company reported negative financial results for two consecutive quarters, including a substantial net loss and low operating cash flow, indicating ongoing challenges in the pharmaceuticals sector.

Read full news article

Recursion Pharmaceuticals Hits Day Low at $4.86 Amid Price Pressure

2025-11-06 16:13:32

Recursion Pharmaceuticals, Inc. has faced a notable decline in its stock performance, with significant losses over various timeframes. The company reports a challenging financial situation, including a substantial net loss and negative return on equity, raising concerns about its market position within the pharmaceuticals and biotechnology sector.

Read full news article

Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators

2025-10-28 16:01:32

Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock has experienced fluctuations in price, with notable performance against the S&P 500 over the past week and month, although longer-term returns have faced challenges. Technical indicators present mixed signals regarding market sentiment.

Read full news article

Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-28 11:41:47

As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD is mildly bullish, while the monthly MACD also indicates a mildly bullish trend. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly time frames. The Dow Theory supports a mildly bullish stance on both weekly and monthly periods, and the OBV is bullish in both time frames. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%. Overall, the mixed signals suggest a cautious approach....

Read full news article

View All News